Key Takeaways
- Domestic strength offsets export weakness: Standalone domestic revenue share jumped from 55% to 67% for the full year, with Q4 domestic growing ~14% while exports degrew ~12%, pulling consolidated growth to a modest 7% YoY.
- Margin held despite a large provision: Consolidated EBITDA before exceptionals rose 28% YoY to ₹213 crores, but reported EBITDA margin slipped from 12% to 11% solely because of a ₹38-39 crore provision; underlying margins were maintained.
- A capex cycle is ending, a new one is beginning: All major ongoing capex completes by June/July 2024, and two new plants (mag carbon brick, casting flux) are ramping up, targeting 50% utilization this year and 80-85% next year.
- Acquisition pipeline is live but opaque: Targets are selected for the US (completely new steel products) and India (existing portfolio products), with movement hoped for this financial year; a European deal was abandoned due to market sentiment.
- What to watch next quarter: Clarity on the Odisha greenfield plant size and timeline, concrete FY25 capex figures, and any sign of stabilization in the Hofmann (Germany) subsidiary, which management expects to stay weak for at least two more quarters.
Domestic vs Export: A Structural Shift
- Domestic share surged: Standalone domestic revenue share moved from 55% (FY23) to 67% (FY24), and from 63% to 77% in Q4 alone, driven by double-digit domestic growth against a declining export book.
- India steel demand is the engine: The World Steel Association projects 8% growth for India over 2024 and 2025, with 2025 demand almost 7 crore tonnes higher than 2020; management called India the strongest driver of steel demand growth since 2021.
- Export pain is concentrated in Europe: The EU/UK region faces the biggest challenges from geopolitical shifts, high inflation, monetary tightening, withdrawal of fiscal support, and high energy and commodity prices; ASEAN struggles with political instability and eroded competitiveness.
- FY25 export ambition is flat to marginal: Management plans to hold exports and grow them marginally by 2% in FY25, while domestic growth is projected around 17%.
McIntosh: "The growth in India is 78% per annum, whereas the best you'll see normally in a very, very good year in America or Europe would be the low 2% or 3% in a very good year."
New Capacity: The Ramp-Up Bet
- Two new plants are now live or near-live: The continuous casting flux plant in Visakhapatnam was inaugurated in May 2024; the magnesia carbon brick plant, also in Visakhapatnam, will be inaugurated in June 2024.
- Mag carbon is a backward-integration play: The mag carbon plant serves existing customers already on the clientele list, so the ramp-up is about capturing volume from known relationships rather than building a new book.
- Ramp-up targets are specific: Mag carbon brick is expected to reach ~50% capacity by end of FY25 and 80-85% by end of FY26; mold flux powder will take slightly longer, reaching 90% in 2.5 to 3 years.
- Brownfield ramp-up mirrors this: 50% utilization this financial year and 80% next year for brownfield capex; flux at 30% this year and 70-80% next year.
- Overall capacity utilization sits at 63-65%: Management aims to improve this, with the major contribution expected from the domestic segment as new plants come online.
Shanmugam: "I'm happy to tell you that this magnesia carbon plant, what we have put up, is actually a backward integration, meaning we already have important customers on our clientele list for consumption of magnesia carbon."
Subsidiary Health: A Tale of Two Geographies
- EIC (USA) is steady and profitable: Sales held at the same level as last year but profitability was much higher; management expects profitability at the same level or slightly higher in FY25, with an expansion project underway to combine operations and double the size.
- Hofmann (Germany) is the problem child: Significant sales and profitability decline driven by the German manufacturing downturn; management expects weak sales and profitability to continue for the next couple of quarters, with improvement hoped for only toward the end of the calendar year.
- Czech customer receivable is secured but stretched: A customer in the Czech Republic went through a creditor restructuring plan successfully; no haircut is expected, but the payment timeline is extended, with payments expected by end of 2025 and the balance in the following year.
Strategic Initiatives: People, Processes, and New Markets
- Cement sector entry is now real: In early 2024, IFGL commenced supply of its own high-alumina brick products into the cement industry, marking the first entry into this sector; the high-alumina plant in Wankaner, Gujarat, dispatched its inaugural products to non-ferrous sectors including cement, glass, coke, lime, and coal gasification.
- Organizational overhaul is underway: A new CEO for India (Arasu Shanmugam) was appointed; the team was restructured with new talent at CXO and senior management levels; Deloitte was brought in to launch a PEOPLE FIRST HR program; and PROJECT GATI was launched to leverage streamlined operations, real-time data analytics, and advanced decision-making.
- R&D is being professionalized: A Chief Research Officer has joined, the team for major product lines is in place, internal benchmarking has progressed well, and one senior employee is going abroad for global benchmarking.
- Automation investment continues: A 100% automatic plant for casting flux was commissioned, and management is exploring automation of other manual activities.
- Employee costs rose on these investments: The SAP implementation, Deloitte appointment, and R&D center build-out pushed employee costs up; management stated this will be made up in future, and clarified that yearly employee cost runs around 8% of standalone revenue.
McIntosh: "We are pleased to announce that in early 2024, we commenced supply of our own high alumina brick products into the cement industry, which is the first entry into this important sector."
Acquisitions: Two Live Targets, One Abandoned
- US target is a new-product entry into steel: The American acquisition would bring completely new products into the company, all within the steel segment; management declined to specify the exact product category when pressed.
- India target is an in-portfolio consolidation play: The Indian acquisition target would involve products currently in IFGL's portfolio, suggesting a market-share or capacity consolidation move.
- A European deal was walked away from: Management had been working on a European acquisition that looked very strong, but decided not to proceed last year because of market sentiments in Europe.
- Timing is hopeful but not committed: Management expressed hope for movement on both the US and India acquisitions within this financial year, but declined to give specific timing.
McIntosh: "American acquisition would be completely new products in the company. The acquisition target in India would be products which we currently have in our portfolio."
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Standalone revenue growth | Continue growth of around 10% | FY25 (annual) |
| Domestic revenue growth | Around 17% growth | FY25 |
| Export revenue growth | Hold and grow marginally by 2% | FY25 |
| Standalone EBITDA margin | 15% | FY25 |
| Consolidated EBITDA margin | 12% | FY25 (annual; no quarterly guidance) |
| Mag carbon brick utilization | ~50% capacity | End of FY25 |
| Mag carbon brick utilization | 80-85% capacity | End of FY26 |
| Mold flux powder utilization | 90% capacity | 2.5 to 3 years |
| Brownfield capex utilization | 50% this year, 80% next year | FY25 / FY26 |
| Flux brownfield utilization | 30% this year, 70-80% next year | FY25 / FY26 |
| All major capex completion | Completed | By June/July 2024 |
| EIC (USA) profitability | Same level as last year or slightly higher | FY25 |
| Hofmann (Germany) performance | Weak sales and profitability to continue | Next couple of quarters |
| Czech customer receivables | Payments received | By end of 2025, balance in following year |
| 2x growth target | Achieve 2x growth | Within next 5 years |
| US and India acquisitions | Hopeful of movement | Within this financial year |
Key Metrics
| Metric | Q4 FY24 |
|---|---|
| Total income (consolidated) | ₹401 cr, up 7% YoY |
| Total income (standalone) | ₹216 cr |
| EBITDA (consolidated) | ₹42 cr |
| EBITDA margin (consolidated) | 10.5%; 12.8% before exceptional items |
| PAT (consolidated) | ₹12.5 cr |
| Cash and cash equivalents (consolidated) | ₹202 cr as of 31st March 2024 |
| Standalone domestic revenue share | 77% of total revenue, up from 63% in Q4 FY23 |
| Standalone export degrowth | ~12% YoY in Q4 |
| Domestic growth projection for FY25 | ~17% |
| Export growth projection for FY25 | ~2% to 2.3% |
| Consolidated EBITDA margin guidance (yearly) | 12% |
| Capacity utilization (overall) | 63% to 65% |
| Sheffield sales (FY24 full year) | ~₹200 cr |
| Provision for exceptional items (FY24) | ₹38 cr to ₹39 cr |
| Debt on book | ₹62 cr, company is net debt-free |